PEGVISOMANT for Pituitary tumour: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 82 adverse event reports in the FDA FAERS database where PEGVISOMANT was used for Pituitary tumour.
Most Reported Side Effects for PEGVISOMANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 460 | 15.3% | 27 | 64 |
| Drug ineffective | 328 | 10.9% | 2 | 32 |
| Insulin-like growth factor increased | 320 | 10.6% | 2 | 43 |
| Product dose omission issue | 255 | 8.5% | 2 | 36 |
| Headache | 244 | 8.1% | 1 | 41 |
| Fatigue | 224 | 7.4% | 6 | 38 |
| Arthralgia | 184 | 6.1% | 1 | 31 |
| Death | 162 | 5.4% | 162 | 11 |
| Injection site pain | 161 | 5.3% | 1 | 23 |
| Product use issue | 158 | 5.2% | 11 | 52 |
| Diarrhoea | 151 | 5.0% | 1 | 39 |
| Nausea | 142 | 4.7% | 0 | 45 |
| Pain | 121 | 4.0% | 0 | 22 |
| Malaise | 114 | 3.8% | 3 | 23 |
| Needle issue | 110 | 3.7% | 0 | 18 |
Other Indications for PEGVISOMANT
Acromegaly (1,911)
Gigantism (252)
Product used for unknown indication (73)
Pituitary tumour benign (48)
Insulin-like growth factor increased (46)
Hypothalamo-pituitary disorder (41)
Neoplasm (27)
Blood growth hormone increased (21)
Brain neoplasm (20)
Insulin-like growth factor abnormal (20)
Other Drugs Used for Pituitary tumour
OCTREOTIDE (137)
SOMATROPIN (121)
CABERGOLINE (84)
TEMOZOLOMIDE (77)
PASIREOTIDE (43)
LANREOTIDE (36)
BROMOCRIPTINE (23)
BEVACIZUMAB (11)
TESTOSTERONE (10)
CAPECITABINE (8)